The World Health Organization (WHO), defines Pharmacovigilance as the science and activities related to detection, evaluation, comprehension and prevention of adverse effects of medicines or any other health problem related to them.

Biopas has culture of safety driven by the patient, our ambition is to help make the world a better place for patients and their families.

The Pharmacovigilance system is a mandatory requirement for the early detection of risks associated to pharmacotherapy and to prevent problems related to medicines.  In addition, it helps health care professionals and Biopas´ patients to get the best benefit-risk ratio with a safe and effective therapy.

Biopas is the Pharmacovigilance representative in the countries in which it is present.  We are committed to follow-up the security profile of our products, in alignment with our licensor´s Pharmacovigilance programs; for this reason we make sure to subject any suspicion of problem related to medicines to the competent national authority and our business partners.

As part of the development of the implementation of the Pharmacovigilance program in Biopas, we make sure:

  1. To identify and report security information of patients who use Biopas´ marketed products.
  2. To prevent harm arising from adverse effects.
  3. To promote the safe use of pharmaceutical products, medical-surgical devices, and cosmetics for the care and maintenance of human health.
  4. ConTo contribute to patient protection and to avoid impact in the public health system.
  5. To conduct scientific evaluation of all adverse reactions´ information.
  6. To promote the participation of all Biopas´ employees in the Pharmacovigilance program.
  7. To encourage cooperation and communication of all members of the organization trending towards the timely and proper report of adverse reactions.

TOLL-FREE NUMBER: +18003491490

PATIENT SAFETY INFORMATION REPORT

Contact Information

Remember that by clicking “Send”, you are authorizing Biopas to send this information and use your contact information.
You will be contacted by a person from the pharmacovigilance team to confirm receipt of your message and request additional information.
The information that you will provide us will be processed specifically in compliance with the local regulatory standards where BIOPAS has operations. In accordance with the purposes described above, you expressly authorize that the personal data that you provided to BIOPAS may be transferred to our licensors worldwide and to the respective regulatory agencies. This may include countries that do not have or have less stringent laws regarding protection of such information. However, any of the parties that handle information on behalf of BIOPAS is obliged to process your personal information in accordance with BIOPAS´ compliance policies. All information received on this website will be used exclusively for purposes related to public health and not for commercial purposes.
Provided that it is permitted by local regulations, if at any time you wish to access, modify, correct or eliminate the personal information you provide to BIOPAS, you may exercise your rights by directing your request to the following electronic address: farmacovigilancia@biopasgroup.com

Start typing and press Enter to search